InnovAge Holding Corp
NASDAQ: INNV · HEALTHCARE · MEDICAL CARE FACILITIES
Updated 2026-05-05
InnovAge Holding Corp (INNV) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for INNV.
Current price exceeds what fundamentals support. Risk/reward skewed unfavorably.
INNV historical valuation range
Where current P/E sits in INNV's own 5Y range.
INNV intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
INNV valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
Current: 159.20x
P/S Ratio — History
Current: 1.18x
Is INNV overvalued in 2026?
InnovAge Holding Corp (INNV) currently trades at $7.96 per share with a market capitalization of $1,080,168,000.00. Based on our multi-factor framework, the stock appears richly valued with a Smart Value Score of 31/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
The stock trades at a P/E ratio of 159.2x, below its 5-year median of 162.4x.
Looking at its own history, INNV is currently trading cheaper than 58% of the last 5Y on P/E. This places it in the 42th percentile of its historical range, a reasonable but unremarkable position.
Our discounted cash flow model estimates INNV's intrinsic value at $15.02 per share, against the current market price of $7.96. This implies a margin of safety of +45.54%. A meaningful cushion exists against model error, making this a reasonable risk-adjusted entry.
The Piotroski F-Score of 5/9 puts financial quality in a middling range, neither a standout strength nor an obvious red flag.
Bottom line: INNV appears richly valued on our framework, with a Smart Value Score of 31/100. At current levels the risk/reward is skewed against the buyer. A materially lower price or significant operational improvement would be needed to change the picture.
Frequently asked questions
Is INNV overvalued in 2026?
Based on a Smart Value Score of 31/100, INNV appears overvalued. Current price exceeds what fundamentals currently justify.
What is INNV's fair value?
Our DCF model estimates INNV's intrinsic value at $15.02 per share, versus the current price of $7.96. This produces a margin of safety of +45.54%.
What P/E ratio does INNV trade at?
INNV trades at a P/E of 159.2x on trailing twelve-month earnings, compared to its 5-year median of 162.4x.
Is INNV a buy based on valuation?
WallStSmart does not issue buy or sell recommendations. Our Smart Value Score of 31/100 reflects the combined read on growth, quality, and price. The profile skews cautious. Consider waiting for a better price or clearer operational improvement.
How does INNV's valuation compare to its history?
On P/E, INNV currently sits in the 42th percentile of its own 5Y range. That is below its long-run median relative to where it has traded over the period.
What is INNV's Smart Value Score?
INNV's Smart Value Score is 31/100. The Smart Value Score is a proprietary WallStSmart metric blending growth quality, financial health, and valuation attractiveness into a single 0-100 read. Scores above 75 are rare and indicate strong multi-factor alignment.